Efficient adenoviral vector transduction and expression of functional human factor VIII in cultured primary human hepatocytes

This publication has 28 references indexed in Scilit:

• Haemophilia A gene therapy
  Haemophilia, 1998
• Gene therapy for haemophilia
  Expert Opinion on Investigational Drugs, 1997
• Gene Therapy for Hemophilia A
  Thrombosis and Haemostasis, 1997
• Development and Analysis of Retroviral Vectors Expressing Human Factor VIII as a Potential Gene Therapy for Hemophilia A
  Human Gene Therapy, 1995
• Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice.
  Proceedings of the National Academy of Sciences, 1995
• Sequences in the Coding Region of Clotting Factor VIII Act as Dominant Inhibitors of RNA Accumulation and Protein Production
  Human Gene Therapy, 1993
• Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII
  Blood, 1993
• Toward Gene Therapy for Hemophilia A: Long-Term Persistence of Factor VIII-Secreting Fibroblasts after Transplantation into Immunodeficient Mice
  Human Gene Therapy, 1993
• Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule
  Biochemistry, 1986
• A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity.
  Proceedings of the National Academy of Sciences, 1986